Musk's Neuralink raises $280 million, pursues human trials despite animal welfare concerns

Neuralink raised $280 million in a new funding round led by Founders Fund.
The company is developing implanted brain-computer interface technology.
Neuralink aims to conduct human clinical trials and has received FDA approval.
Critics have raised concerns about rushed and botched animal surgeries by Neuralink.
U.S. lawmakers called for an investigation into potential conflicts of interest in Neuralink's animal testing oversight.